Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/265600
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Tumor-derived pericytes driven by egfr mutations govern the vascular and immune microenvironment of gliomas |
Autor: | Segura-Collar, Berta; Garranzo Asensio, María; Herranz, Beatriz CSIC ORCID ; Hernández-SanMiguel, Esther CSIC ORCID; Cejalvo, Teresa; Casas, Bárbara S.; Matheu, Ander; Pérez-Núñez, Angel; Sepúlveda-Sánchez, Juan Manuel; Hernández-Laín, Aurelio; Palma, Verónica; Gargini, Ricardo CSIC ORCID; Sánchez-Gómez, Pilar CSIC | Fecha de publicación: | 15-abr-2021 | Editor: | American Association for Cancer Research | Citación: | Cancer Research 81(8): 2142-2156 (2021) | Resumen: | The extraordinary plasticity of glioma cells allows them to contribute to different cellular compartments in tumor vessels, reinforcing the vascular architecture. It was recently revealed that targeting glioma-derived pericytes, which represent a big percentage of the mural cell population in aggressive tumors, increases the permeability of the vessels and improves the efficiency of chemotherapy. However, the molecular determinants of this transdifferentiation process have not been elucidated. Here we show that mutations in EGFR stimulate the capacity of glioma cells to function as pericytes in a BMX- (bone marrow and X-linked) and SOX9-dependent manner. Subsequent activation of platelet-derived growth factor receptor beta in the vessel walls of EGFR-mutant gliomas stabilized the vasculature and facilitated the recruitment of immune cells. These changes in the tumor microenvironment conferred a growth advantage to the tumors but also rendered them sensitive to pericyte-targeting molecules such as ibrutinib or sunitinib. In the absence of EGFR mutations, high-grade gliomas were enriched in blood vessels, but showed a highly disrupted blood–brain barrier due to the decreased BMX/SOX9 activation and pericyte coverage, which led to poor oxygenation, necrosis, and hypoxia. Overall, these findings identify EGFR mutations as key regulators of the glioma-to-pericyte transdifferentiation, highlighting the intricate relationship between the tumor cells and their vascular and immune milieu. Our results lay the foundations for a vascular-dependent stratification of gliomas and suggest different therapeutic vulnerabilities determined by the genetic status of EGFR. | Versión del editor: | http://dx.doi.org/10.1158/0008-5472.CAN-20-3558 | URI: | http://hdl.handle.net/10261/265600 | DOI: | 10.1158/0008-5472.CAN-20-3558 | ISSN: | 0008-5472 | E-ISSN: | 1538-7445 |
Aparece en las colecciones: | (IIBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Tumor-derived_pericytes_driven_Segura_Postprint_Art2021.pdf | 4,84 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
18
checked on 21-abr-2024
WEB OF SCIENCETM
Citations
17
checked on 24-feb-2024
Page view(s)
234
checked on 28-abr-2024
Download(s)
73
checked on 28-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.